PDB: 1008 resultsInfo pagesStatus searchChemie searchBIRD

---

6BTI	Crystal structure of human cellular retinol binding protein 2 (CRBP2) in complex with N-arachidonoylethanolamine (AEA) Descriptor: (5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide, DI(HYDROXYETHYL)ETHER, Retinol-binding protein 2 Authors: Silvaroli, J.A, Blaner, W.S, Lodowski, D.T, Golczak, M. Deposit date: 2017-12-06 Release date: 2018-12-12 Last modified: 2023-10-04 Method: X-RAY DIFFRACTION (1.45 Å) Cite: Retinol-binding protein 2 (RBP2) binds monoacylglycerols and modulates gut endocrine signaling and body weight. Sci Adv, 6, 2020
6BTH	Crystal structure of human cellular retinol binding protein 2 (CRBP2) in complex with 2-arachidonoylglycerol (2-AG) Descriptor: 1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate, DI(HYDROXYETHYL)ETHER, Retinol-binding protein 2 Authors: Silvaroli, J.A, Blaner, W.S, Lodowski, D.T, Golczak, M. Deposit date: 2017-12-06 Release date: 2018-12-12 Last modified: 2023-10-04 Method: X-RAY DIFFRACTION (1.35 Å) Cite: Retinol-binding protein 2 (RBP2) binds monoacylglycerols and modulates gut endocrine signaling and body weight. Sci Adv, 6, 2020
6AYL	Human adipocyte lipid-binding protein FABP4 in complex with fluorescein Descriptor: 2-(6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)-BENZOIC ACID, Fatty acid-binding protein, adipocyte Authors: Pozharski, E. Deposit date: 2017-09-08 Release date: 2018-09-12 Last modified: 2023-10-04 Method: X-RAY DIFFRACTION (1.86 Å) Cite: To be published To Be Published
2FS6	Crystal Structure of Apo-Cellular Retinoic Acid Binding Protein Type II At 1.35 Angstroms Resolution Descriptor: ACETATE ION, CHLORIDE ION, Cellular retinoic acid-binding protein 2, ... Authors: Vaezeslami, S, Geiger, J.H. Deposit date: 2006-01-21 Release date: 2006-09-19 Last modified: 2024-02-14 Method: X-RAY DIFFRACTION (1.35 Å) Cite: The structure of Apo-wild-type cellular retinoic acid binding protein II at 1.4 A and its relationship to ligand binding and nuclear translocation. J.Mol.Biol., 363, 2006
2FR3	Crystal Structure of Cellular Retinoic Acid Binding Protein Type II in Complex with All-Trans-Retinoic Acid at 1.48 Angstroms Resolution Descriptor: ACETATE ION, Cellular retinoic acid binding protein 2, RETINOIC ACID Authors: Vaezeslami, S, Geiger, J.H. Deposit date: 2006-01-18 Release date: 2006-09-19 Last modified: 2024-02-14 Method: X-RAY DIFFRACTION (1.48 Å) Cite: The structure of Apo-wild-type cellular retinoic acid binding protein II at 1.4 A and its relationship to ligand binding and nuclear translocation. J.Mol.Biol., 363, 2006
2FS7	Crystal Structure of Apo-Cellular Retinoic Acid Binding Protein Type II At 1.55 Angstroms Resolution Descriptor: ACETATE ION, CHLORIDE ION, Cellular retinoic acid-binding protein 2 Authors: Vaezeslami, S, Geiger, J.H. Deposit date: 2006-01-21 Release date: 2006-09-19 Last modified: 2024-02-14 Method: X-RAY DIFFRACTION (1.55 Å) Cite: The structure of Apo-wild-type cellular retinoic acid binding protein II at 1.4 A and its relationship to ligand binding and nuclear translocation. J.Mol.Biol., 363, 2006
2FT9	Crystal structure of axolotl (Ambystoma mexicanum) liver bile acid-binding protein bound to cholic acid Descriptor: CHOLIC ACID, Fatty acid-binding protein 2, liver Authors: Capaldi, S, Guariento, M, Perduca, M, Di Pietro, S.M, Santome, J.A, Monaco, H.L. Deposit date: 2006-01-24 Release date: 2006-04-11 Last modified: 2023-10-25 Method: X-RAY DIFFRACTION (2.5 Å) Cite: Crystal structure of axolotl (Ambystoma mexicanum) liver bile acid-binding protein bound to cholic and oleic acid Proteins, 64, 2006
6O5D	PYOCHELIN Descriptor: GLYCEROL, Neutrophil gelatinase-associated lipocalin, SULFATE ION Authors: Rupert, P.B, Strong, R.K, Clifton, M.C, Edwards, T.E, Seattle Structural Genomics Center for Infectious Disease (SSGCID) Deposit date: 2019-03-01 Release date: 2019-09-11 Last modified: 2020-07-29 Method: X-RAY DIFFRACTION (2.4 Å) Cite: Parsing the functional specificity of Siderocalin/Lipocalin 2/NGAL for siderophores and related small-molecule ligands. J Struct Biol X, 2, 2019
6ON5	Crystal Structure of the Zn-bound Domain-Swapped Dimer Q108K:T51D:A28C:L36C:F57H Mutant of Human Cellular Retinol Binding Protein II Descriptor: Retinol-binding protein 2, ZINC ION Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2019-04-20 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.638 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6ON8	Crystal Structure of the Reduced Form of Apo Domain-Swapped Dimer Q108K:T51D:A28C:L36C:F57H Mutant of Human Cellular Retinol Binding Protein II Descriptor: Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2019-04-20 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (2.395 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
2G78	Crystal Structure of the R132K:Y134F Mutant of Cellular Retinoic Acid Binding Protein Type II in Complex with All-Trans-Retinoic Acid at 1.70 Angstroms Resolution Descriptor: Cellular retinoic acid-binding protein 2, RETINOIC ACID, SODIUM ION Authors: Vaezeslami, S, Geiger, J.H. Deposit date: 2006-02-27 Release date: 2007-04-17 Last modified: 2024-02-14 Method: X-RAY DIFFRACTION (1.7 Å) Cite: Protein design: reengineering cellular retinoic acid binding protein II into a rhodopsin protein mimic. J.Am.Chem.Soc., 129, 2007
2G7B	Crystal Structure of the R132K:R111L:L121E mutant of Cellular Retinoic Acid Binding Protein Type II In Complex With All-Trans-Retinal At 1.18 Angstroms Resolution Descriptor: ALL-TRANS AXEROPHTHENE, Cellular retinoic acid-binding protein 2, SODIUM ION Authors: Vaezeslami, S, Geiger, J.H. Deposit date: 2006-02-27 Release date: 2007-04-17 Last modified: 2021-10-20 Method: X-RAY DIFFRACTION (1.18 Å) Cite: Protein design: reengineering cellular retinoic acid binding protein II into a rhodopsin protein mimic. J.Am.Chem.Soc., 129, 2007
2G79	Crystal Structure of the R132K:Y134F Mutant of Cellular Retinoic Acid Binding Protein Type II in Complex with All-Trans-Retinal at 1.69 Angstroms Resolution Descriptor: Cellular retinoic acid-binding protein 2, RETINAL, SODIUM ION, ... Authors: Vaezeslami, S, Geiger, J.H. Deposit date: 2006-02-27 Release date: 2007-04-17 Last modified: 2024-02-14 Method: X-RAY DIFFRACTION (1.69 Å) Cite: Protein design: reengineering cellular retinoic acid binding protein II into a rhodopsin protein mimic. J.Am.Chem.Soc., 129, 2007
6ON7	Crystal Structure of Apo Domain-Swapped Dimer Q108K:T51D:A28C:L36C Mutant of Human Cellular Retinol Binding Protein II Descriptor: Retinol-binding protein 2 Authors: Ghanbarpour, A, Geiger, J. Deposit date: 2019-04-20 Release date: 2019-10-16 Last modified: 2023-10-11 Method: X-RAY DIFFRACTION (1.981 Å) Cite: Engineering the hCRBPII Domain-Swapped Dimer into a New Class of Protein Switches. J.Am.Chem.Soc., 141, 2019
6QI6	Trigonal form of WT recombinant bovine beta-lactoglobulin Descriptor: 1,2-ETHANEDIOL, Beta-lactoglobulin, ETHANOL Authors: Loch, J.I, Krawczyk, A, Lewinski, K. Deposit date: 2019-01-17 Release date: 2019-01-30 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6QI7	Engineered beta-lactoglobulin: variant L39Y in complex with endogenous ligand Descriptor: 1,2-ETHANEDIOL, Beta-lactoglobulin, PALMITIC ACID Authors: Loch, J.I, Siuda, M.K, Lewinski, K. Deposit date: 2019-01-17 Release date: 2019-01-30 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.5 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
5X7Y	Crystal Structure of the Dog Lipocalin Allergen Can f 6 Descriptor: DI(HYDROXYETHYL)ETHER, Lipocalin-Can f 6 allergen Authors: Yamamoto, K, Otani, T, Sugiura, K, Nakatsuji, M, Nishimura, S, Inui, T. Deposit date: 2017-02-28 Release date: 2018-04-04 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (2.35 Å) Cite: Crystal structure of the dog allergen Can f 6 and structure-based implications of its cross-reactivity with the cat allergen Fel d 4. Sci Rep, 9, 2019
5Y0G	Crystal structure of human FABP4 complexed with ligand 4-Fluoro-3-((4-methoxynaphthalene)-1-sulfonamido) benzoic acid Descriptor: 4-fluoranyl-3-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid, Fatty acid-binding protein, adipocyte Authors: Su, H.X, Liu, Q.F, Xu, Y.C. Deposit date: 2017-07-17 Release date: 2018-06-06 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (1.542 Å) Cite: From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4 Eur J Med Chem, 154, 2018
5Y0X	Crystal structure of human FABP4 complexed with ligand 2-fluoro-3-((4-methoxynaphthalene)-1-sulfonamido)benzoic acid Descriptor: 2-fluoranyl-3-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid, Fatty acid-binding protein, adipocyte Authors: Su, H.X, Liu, Q.F, Xu, Y.C. Deposit date: 2017-07-19 Release date: 2018-06-06 Last modified: 2024-03-27 Method: X-RAY DIFFRACTION (1.604 Å) Cite: From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4 Eur J Med Chem, 154, 2018
5Y13	Crystal structure of human FABP4 complexed with ligand 5-((4-bromonaphthalene)-1-sulfonamido)pentanoic acid Descriptor: 5-[(4-bromanylnaphthalen-1-yl)sulfonylamino]pentanoic acid, Fatty acid-binding protein, adipocyte Authors: Su, H.X, Liu, Q.F, Xu, Y.C. Deposit date: 2017-07-19 Release date: 2018-06-06 Last modified: 2024-03-27 Method: X-RAY DIFFRACTION (1.75 Å) Cite: From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4 Eur J Med Chem, 154, 2018
5WY9	Apo form crystal structure of human Lipocalin PGDS . Descriptor: 2-(2-METHOXYETHOXY)ETHANOL, 2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL, Prostaglandin-H2 D-isomerase Authors: Saif, M, Pervushin, K. Deposit date: 2017-01-11 Release date: 2017-01-25 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (1.45 Å) Cite: To be published To Be Published
5Y5C	Crystal structure of dha bind to bovine beta-lactoglobulin Descriptor: Beta-lactoglobulin, DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID Authors: Jiang, L, Liu, J. Deposit date: 2017-08-08 Release date: 2018-08-08 Last modified: 2023-11-22 Method: X-RAY DIFFRACTION (2.61 Å) Cite: Crystal structure of dha bind to bovine beta-lactoglobulin To Be Published
5Y0F	Crystal structure of human FABP4 complexed with ligand 2-fluoro-5-((4-methoxynaphthalene)-1-sulfonamido) benzoic acid Descriptor: 2-fluoranyl-5-[(4-methoxynaphthalen-1-yl)sulfonylamino]benzoic acid, Fatty acid-binding protein, adipocyte Authors: Su, H.X, Liu, Q.F, Xu, Y.C. Deposit date: 2017-07-17 Release date: 2018-06-06 Last modified: 2024-03-27 Method: X-RAY DIFFRACTION (1.54 Å) Cite: From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4 Eur J Med Chem, 154, 2018
5Y12	Crystal structure of human FABP4 complexed with ligand 5-((4-methoxynaphthalene)-1-sulfonamido)pentanoic acid Descriptor: 5-[(4-methoxynaphthalen-1-yl)sulfonylamino]pentanoic acid, Fatty acid-binding protein, adipocyte Authors: Su, H.X, Liu, Q.F, Xu, Y.C. Deposit date: 2017-07-19 Release date: 2018-06-06 Last modified: 2024-03-27 Method: X-RAY DIFFRACTION (1.75 Å) Cite: From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4 Eur J Med Chem, 154, 2018
7OUB	High resolution structure of Alpha-1-acid glycoprotein bound to potent anti-tumour compound UCN-01 Descriptor: 7-HYDROXYSTAUROSPORINE, Alpha-1-acid glycoprotein 2 Authors: Landin, E.J.B, Williams, C, Crump, M.P. Deposit date: 2021-06-11 Release date: 2021-12-01 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.82 Å) Cite: The structural basis for high affinity binding of alpha 1-acid glycoprotein to the potent antitumor compound UCN-01. J.Biol.Chem., 297, 2021

<12345678910111213141516>